Genomic diagnosis at the service of the Rare Disease Clinic
in patients with rare diseases (2015–2025)
in association with rare diseases
in association with rare diseases not found in the literature
indexed in the Italian population
OUR ANALYSES
NGS analysis
Whole-exome sequencing (WES)
Inherited disorders with low, medium and high genetic heterogeneity: whole-exome sequencing with phenotype-driven analysis of all genes currently associated with the suspected disorders and, in the most complex cases, reverse phenotyping.
Esoma as part of a trio
Inherited disorders with very high genetic heterogeneity: exome sequencing of the patient and their parents, with phenotype-guided analysis and reverse phenotyping, to identify de novo variants and determine the mode of inheritance.
EXOME ANALYSIS IN A NUTSHELL:
- Over 300 conditions investigated across 14 clinical areas
- Analysis guided by the clinical phenotype and reverse phenotyping in the most complex cases
- Over 3000 clinically relevant genes
- Average sequencing depth 100x, average coverage 99%
- Identification of single-nucleotide variants (SNVs) and copy-number variations (CNVs)
Single gene variant search
R&I Genetics offers the service of targeted analysis of one or more specifically requested genes. These must be indicated in the analysis request form in the dedicated section. The analysis will be performed by means of NGS or Sanger sequencing.
Family segregation search for known variants
R&I Genetics offers the service of searching for known family variants. The analysis is performed by means of Sanger resequencing, and for access it is necessary to indicate the nucleotide substitution and the corresponding transcript code (e.g. search for variant c.91C>T in the CFTR gene NM_000492).
CGH Array
CGH ARRAY 400k
Array Agilent GenetiSure Postnatal Research CGH+SNP Microarray, 2x400K, average resolution 9.5 Kb, exon coverage ISCA genes: 89% ≧ 3 probes per exon; analysis using Agilent CytoGenomics 5.0.2.5 software.
CGH ARRAY 180k
Agilent GenetiSure Cyto 4x180K CGH array, average resolution 16.5 Kb (from 3.5kb in RefSeq genes to 19.8kb in the backbone), analysis performed using Agilent CytoGenomics 5.0.2.5 software.
MLPA
Multiplex Ligation-dependent Probe Amplification (MLPA) is a molecular technique used to detect changes in the copy number of exons or portions of specific genes. Access to the analysis requires the indication of the gene for which the test is to be conducted.
TP-PCR
TP-PCR is a method for identifying the presence of mutations from repeat zone expansion, usually triplets and hexanucleotides. R&I Genetics has methodologies for the analysis of X-Fragile (FMR1), Huntington's disease (HTT), myotonic dystrophy type 1 (DMPK), frontotemporal dementia, ALS (C9orf72) and ataxias (SCA1, SCA2, SCA3, SCA6, SCA7, SCA12, SCA17 and DRPLA).
Clinical areas
Why choose R&I Genetics
5
Next to the doctor
Pre-test support in selecting the appropriate test, post-test support in interpreting the results
















